From molecular networks to the clinic: a systems biology–nanomedicine roadmap for osteoarthritis diagnosis, regeneration, and safety-by-design
Abstract
Osteoarthritis (OA) is a severe, whole-joint illness that is characterized by the permanent destruction of articular cartilage. The failure of traditional therapies and early tissue engineering efforts is mainly due to their reductionist biological strategies and reliance on bulk, non-biomimetic materials that cannot replicate the complex nanoscale architecture of the native extracellular matrix. This review proposes a closed-loop, multidisciplinary roadmap that integrates systems biology and biomimetic nanomedicine to advance OA diagnosis, cartilage regeneration, and nanomaterial safety-by-design. Systems biology, through the application of high-throughput omics data and computational network modeling, identifies the complex transcriptomic and proteomic disturbances that underlie OA and provides accurate molecular blueprints for intervention. Nanotechnology makes these plans real in the physical world in two different ways. Ultra-sensitive systems, such as microfluidic lab-on-a-chip devices and Surface-Enhanced Raman Scattering (SERS) sensors, enable real-time detection of preclinical nanobiomarkers for diagnostic purposes. Engineered nanostructures, such as biomimetic nanocomposites, topographically optimized electrospun scaffolds, and stimuli-responsive nanocarriers, provide specific biophysical and biochemical signals that can restore chondrogenesis by stopping catabolic inflammation from a therapeutic perspective. Finally, as a translational bridge, we highlight the burgeoning discipline of systems toxicology, which uses computational frameworks to achieve genomic biocompatibility and safety-by-design for new nanomaterials. The combination of predictive computer modeling and nanoscale engineering together provides a complete roadmap from the bench to the patient's bedside for the personalized, curative treatment of osteoarthritis.
Related
- Impact of contrasting silvicultural strategies on broadleaved forest regeneration under various levels of ungulate pressure and changing climate in Belgium
- Regeneration and Recyclability of Magnetic Nanomaterials for Multi-Cycle Water Treatment: Toward Circular Adsorption–Desorption Systems
- Fe-AC nanocomposites derived from agro-waste biosorbents: a systematic review of synthesis routes, adsorption mechanisms, regeneration, and environmental sustainability.
- Bioinspired Synthesis of Propolis-Capped Silver Nanoparticles for Rapid Azo Dye Adsorption: Experimental Performance, Thermodynamic Evaluation, Regeneration, and Computational Insights
- Squirrels reduce post-fire regeneration potential in serotinous pines
BibTeX
@article{dortaj2026from,
title = {{From molecular networks to the clinic: a systems biology–nanomedicine roadmap for osteoarthritis diagnosis, regeneration, and safety-by-design}},
author = {Hengameh Dortaj and Abbas Asoudeh-Fard and Aliakbar Alizadeh and Ahmad Vaez and Ahmad Gholami},
journal = {Discover Nano},
year = {2026},
month = sep,
doi = {10.1186/s11671-026-04938-3},
url = {https://hal.science/hal-05767905v1},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - From molecular networks to the clinic: a systems biology–nanomedicine roadmap for osteoarthritis diagnosis, regeneration, and safety-by-design
AU - Hengameh Dortaj
AU - Abbas Asoudeh-Fard
AU - Aliakbar Alizadeh
AU - Ahmad Vaez
AU - Ahmad Gholami
PY - 2026
DA - 2026/09/21
JO - Discover Nano
DO - 10.1186/s11671-026-04938-3
UR - https://hal.science/hal-05767905v1
AB - Osteoarthritis (OA) is a severe, whole-joint illness that is characterized by the permanent destruction of articular cartilage. The failure of traditional therapies and early tissue engineering efforts is mainly due to their reductionist biological strategies and reliance on bulk, non-biomimetic materials that cannot replicate the complex nanoscale architecture of the native extracellular matrix. This review proposes a closed-loop, multidisciplinary roadmap that integrates systems biology and biomimetic nanomedicine to advance OA diagnosis, cartilage regeneration, and nanomaterial safety-by-design. Systems biology, through the application of high-throughput omics data and computational network modeling, identifies the complex transcriptomic and proteomic disturbances that underlie OA and provides accurate molecular blueprints for intervention. Nanotechnology makes these plans real in the physical world in two different ways. Ultra-sensitive systems, such as microfluidic lab-on-a-chip devices and Surface-Enhanced Raman Scattering (SERS) sensors, enable real-time detection of preclinical nanobiomarkers for diagnostic purposes. Engineered nanostructures, such as biomimetic nanocomposites, topographically optimized electrospun scaffolds, and stimuli-responsive nanocarriers, provide specific biophysical and biochemical signals that can restore chondrogenesis by stopping catabolic inflammation from a therapeutic perspective. Finally, as a translational bridge, we highlight the burgeoning discipline of systems toxicology, which uses computational frameworks to achieve genomic biocompatibility and safety-by-design for new nanomaterials. The combination of predictive computer modeling and nanoscale engineering together provides a complete roadmap from the bench to the patient's bedside for the personalized, curative treatment of osteoarthritis.
SN - 2731-9229
ER -